NYSE - Nasdaq Real Time Price • USD
Catalent, Inc. (CTLT)
As of 3:07 PM EDT. Market Open.
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Cash Flow
174,000.00
254,000.00
439,000.00
433,000.00
440,000.00
Investing Cash Flow
-410,000.00
-955,000.00
-1,884,000.00
-649,000.00
-827,000.00
Financing Cash Flow
8,000.00
521,000.00
1,031,000.00
142,000.00
1,002,000.00
End Cash Position
214,000.00
280,000.00
449,000.00
896,000.00
953,000.00
Income Tax Paid Supplemental Data
92,000.00
99,000.00
53,000.00
47,000.00
43,000.00
Interest Paid Supplemental Data
217,000.00
188,000.00
116,000.00
105,000.00
98,000.00
Capital Expenditure
-437,000.00
-576,000.00
-660,000.00
-686,000.00
-466,000.00
Issuance of Capital Stock
--
--
--
82,000.00
1,046,000.00
Issuance of Debt
905,000.00
715,000.00
1,100,000.00
166,000.00
909,000.00
Repayment of Debt
-920,000.00
-230,000.00
-78,000.00
-67,000.00
-49,500.00
Free Cash Flow
-263,000.00
-322,000.00
-221,000.00
-253,000.00
-26,000.00
6/30/2020 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ELAN Elanco Animal Health Incorporated
13.33
+2.22%
PETQ PetIQ, Inc.
16.53
+1.29%
TAK Takeda Pharmaceutical Company Limited
13.05
-0.19%
RDY Dr. Reddy's Laboratories Limited
74.57
+0.74%
NBIX Neurocrine Biosciences, Inc.
136.13
-1.19%
AMPH Amphastar Pharmaceuticals, Inc.
41.25
+1.03%
ALKS Alkermes plc
24.74
+1.23%
HLN Haleon plc
8.48
+0.89%
BHC Bausch Health Companies Inc.
8.72
+1.10%
ITCI Intra-Cellular Therapies, Inc.
72.77
+0.89%